{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:54:46Z","timestamp":1790456086900,"version":"4.1.0"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"\n Importance<\/jats:title>\n Pure autonomic failure (PAF) can be the prodromal presentation of Parkinson disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA), although phenoconversion rates and predictors have not been systematically reported.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To estimate phenoconversion rates for MSA, PD, and DLB separately and grouped as central \u03b1-synucleinopathies and identify clinical predictors of phenoconversion in patients with PAF.<\/jats:p>\n <\/jats:sec>\n \n Data Sources<\/jats:title>\n PubMed and Embase databases from inception to June 2025.<\/jats:p>\n <\/jats:sec>\n \n Study Selection<\/jats:title>\n Longitudinal studies including patients with confirmed PAF reporting data on incidence and\/or predictors of phenoconversion.<\/jats:p>\n <\/jats:sec>\n \n Data Extraction and Synthesis<\/jats:title>\n \n Studies were screened and data extracted by 2 independent investigators according to\n PRISMA<\/jats:ext-link>\n guidelines. A meta-analysis was performed using generic inverse-variance random-effects models.\n <\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n PD, DLB, MSA, and central \u03b1-synucleinopathy phenoconversion incidence rates as per 100 person-years were the main outcomes. Incidence rates were log transformed and pooled using a random-effects meta-analysis. Clinical predictors of phenoconversion were reported as secondary outcomes. Prediction intervals and meta-regression explored study-level moderators.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 9 studies comprising 900 individuals with PAF (mean [SD] age at onset, 63.1 [4.3] years; 63.8% male) were included. During the mean (SD) 6.4\u2009(2.0) years of follow-up, 270 of 900 individuals with PAF (30%) experienced phenoconversion to a central \u03b1-synucleinopathy (12% to MSA, 11% to DLB, 7% to PD) with a pooled incidence rate of 5.09 per 100 person-years (95% CI, 3.79-6.85; approximately 5% per year). Phenoconversion rates for MSA (pooled incidence rate, 1.96; 95% CI, 1.29-2.99) were highest in the first years of follow-up, whereas Lewy body disorders showed more constant phenoconversion rates (DLB pooled incidence rate, 1.56; 95% CI, 0.94-2.61; PD pooled incidence rate, 1.35; 95% CI, 0.75-2.41). Hyposmia was the only predictor with diagnostic value to distinguish between those with phenoconversion to PD and DLB (hyposmia pooled risk ratio, 1.88; 95% CI, 1.26-2.97) and MSA, although rapid eye movement sleep behavior disorder (RBD) and subtle motor signs were consistent predictors of phenoconversion to any central \u03b1-synucleinopathy. Heterogeneity was partly explained by follow-up duration.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n Findings of this systematic review and meta-analysis suggest that PAF may be a prodromal presentation of PD, DLB, or MSA with phenoconversion incidence rates similar to those of RBD. A combination of clinical (RBD, subtle motor signs, hyposmia) and in-development biomarkers may help refine the phenoconversion trajectories of people with PAF providing an invaluable opportunity for early diagnosis and intervention.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamaneurol.2026.0989","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T15:30:26Z","timestamp":1777908626000},"page":"616","source":"Crossref","is-referenced-by-count":5,"title":["Phenoconversion in Pure Autonomic Failure"],"prefix":"10.1001","volume":"83","author":[{"given":"Sasivimol","family":"Virameteekul","sequence":"first","affiliation":[{"name":"Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom"},{"name":"Department of Biochemistry, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Bonini","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Campese","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria"},{"name":"Department of Neurology, Azienda Sanitaria Universitaria Integrata del Trentino, Trento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Mahlknecht","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Poewe","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair J.","family":"Noyce","sequence":"additional","affiliation":[{"name":"Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom"},{"name":"Neurology Department, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Fanciulli","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"de Pablo-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"noi260023r1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0002-8703(25)90007-5","article-title":"Postural hypotension: a report of 3 cases.","volume":"1","author":"Bradbury","year":"1925","journal-title":"Am Heart J"},{"issue":"10","key":"noi260023r2","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/j.mayocp.2019.03.009","article-title":"Pure autonomic failure.","volume":"94","author":"Coon","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"noi260023r3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/BF02291236","article-title":"Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy.","volume":"6","author":"Kaufmann","year":"1996","journal-title":"Clin Auton Res"},{"issue":"2","key":"noi260023r4","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/brain\/awaf191","article-title":"Pure autonomic failure: a natural history study of the Queen Square cohort.","volume":"149","author":"Chiaro","year":"2026","journal-title":"Brain"},{"issue":"7","key":"noi260023r5","doi-asserted-by":"publisher","first-page":"e889","DOI":"10.1212\/WNL.0000000000010002","article-title":"Predicting phenoconversion in pure autonomic failure.","volume":"95","author":"Coon","year":"2020","journal-title":"Neurology"},{"issue":"2","key":"noi260023r6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/ana.24877","article-title":"Natural history of pure autonomic failure: a US prospective cohort.","volume":"81","author":"Kaufmann","year":"2017","journal-title":"Ann Neurol"},{"issue":"6","key":"noi260023r7","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s10286-023-00987-1","article-title":"Cardiac 18F-dopamine positron emission tomography predicts the type of phenoconversion of pure autonomic failure.","volume":"33","author":"Lenka","year":"2023","journal-title":"Clin Auton Res"},{"issue":"3","key":"noi260023r8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s10286-020-00674-5","article-title":"Autonomic dysfunction and phenoconversion in idiopathic REM sleep behavior disorder.","volume":"30","author":"McCarter","year":"2020","journal-title":"Clin Auton Res"},{"issue":"7","key":"noi260023r9","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1093\/brain\/awae033","article-title":"Phenoconversion in pure autonomic failure: a multicenter prospective longitudinal cohort study.","volume":"147","author":"Millar Vernetti","year":"2024","journal-title":"Brain"},{"issue":"5","key":"noi260023r10","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/mds.25445","article-title":"Prodromal autonomic symptoms and signs in Parkinson disease and dementia with Lewy bodies.","volume":"28","author":"Postuma","year":"2013","journal-title":"Mov Disord"},{"issue":"12","key":"noi260023r11","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1212\/WNL.0000000000003737","article-title":"Pure autonomic failure: predictors of conversion to clinical CNS involvement.","volume":"88","author":"Singer","year":"2017","journal-title":"Neurology"},{"issue":"6","key":"noi260023r12","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/ana.26089","article-title":"Alpha-synuclein oligomers and neurofilament light chain predict phenoconversion of pure autonomic failure.","volume":"89","author":"Singer","year":"2021","journal-title":"Ann Neurol"},{"issue":"5","key":"noi260023r13","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1212\/WNL.46.5.1470","article-title":"Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy.","volume":"46","author":"The Consensus Committee of the American Autonomic Society and the American Academy of Neurology","year":"1996","journal-title":"Neurology"},{"key":"noi260023r14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0072-9752(07)83014-4","article-title":"Autonomic dysfunction in Parkinson disease.","volume":"83","author":"Kaufmann","year":"2007","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"noi260023r15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/ana.25834","article-title":"Validation of the neurogenic orthostatic hypotension ratio with active standing.","volume":"88","author":"Fanciulli","year":"2020","journal-title":"Ann Neurol"},{"issue":"3","key":"noi260023r17","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3390\/biomedinformatics2030028","article-title":"Application of standardized regression coefficient in meta-analysis.","volume":"2","author":"Nieminen","year":"2022","journal-title":"BioMedInformatics"},{"issue":"4","key":"noi260023r19","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/mds.30119","article-title":"Central involvement in pure autonomic failure: insights from neuromelanin-sensitive magnetic resonance imaging and 18F-fluorodopa-positron emission tomography.","volume":"40","author":"Trujillo","year":"2025","journal-title":"Mov Disord"},{"issue":"13","key":"noi260023r20","doi-asserted-by":"publisher","first-page":"e1245","DOI":"10.1212\/WNL.0000000000006243","article-title":"The natural history of idiopathic autonomic failure: the IAF-BO cohort study.","volume":"91","author":"Giannini","year":"2018","journal-title":"Neurology"},{"issue":"5","key":"noi260023r21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/jnnp.64.5.683","article-title":"REM sleep behavior disorder differentiates pure autonomic failure from multiple system atrophy with autonomic failure.","volume":"64","author":"Plazzi","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"noi260023r23","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.776847","article-title":"Global trends in the incidence, prevalence, and years lived with disability of Parkinson disease in 204 countries\/territories from 1990 to 2019.","volume":"9","author":"Ou","year":"2021","journal-title":"Front Public Health"},{"issue":"S1","key":"noi260023r24","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1017\/cjn.2016.2","article-title":"The prevalence and incidence of dementia with Lewy bodies: a systematic review.","volume":"43","author":"Hogan","year":"2016","journal-title":"Can J Neurol Sci"},{"issue":"5","key":"noi260023r25","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.neurol.2023.11.013","article-title":"Prevalence of multiple system atrophy: a literature review.","volume":"180","author":"Kaplan","year":"2024","journal-title":"Rev Neurol (Paris)"},{"issue":"3","key":"noi260023r26","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/brain\/awz030","article-title":"Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behavior disorder: a multicenter study.","volume":"142","author":"Postuma","year":"2019","journal-title":"Brain"},{"issue":"1","key":"noi260023r27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11065-022-09572-1","article-title":"Neuropsychological changes in isolated REM sleep behavior disorder: a systematic review and meta-analysis of cross-sectional and longitudinal studies.","volume":"34","author":"Leitner","year":"2024","journal-title":"Neuropsychol Rev"},{"issue":"4","key":"noi260023r28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S1474-4422(16)00057-0","article-title":"Idiopathic rapid eye movement sleep behavior disorder: diagnosis, management, and the need for neuroprotective interventions.","volume":"15","author":"Iranzo","year":"2016","journal-title":"Lancet Neurol"},{"key":"noi260023r29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.smrv.2018.09.008","article-title":"The risk of neurodegeneration in REM sleep behavior disorder: a systematic review and meta-analysis of longitudinal studies.","volume":"43","author":"Galbiati","year":"2019","journal-title":"Sleep Med Rev"},{"issue":"3","key":"noi260023r30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10286-025-01121-z","article-title":"The phenotype of \u201cpure\u201d autonomic failure.","volume":"35","author":"Coon","year":"2025","journal-title":"Clin Auton Res"},{"issue":"6","key":"noi260023r31","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/mds.29779","article-title":"The motor dysfunction seen in isolated REM sleep behavior disorder.","volume":"39","author":"Simonet","year":"2024","journal-title":"Mov Disord"},{"issue":"Pt 6","key":"noi260023r32","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1093\/brain\/aws093","article-title":"How does parkinsonism start\u2014prodromal parkinsonism motor changes in idiopathic REM sleep behavior disorder.","volume":"135","author":"Postuma","year":"2012","journal-title":"Brain"},{"issue":"16","key":"noi260023r33","doi-asserted-by":"publisher","first-page":"e1528","DOI":"10.1212\/WNL.0000000000006366","article-title":"Smartphone motor testing to distinguish idiopathic REM sleep behavior disorder, controls, and PD.","volume":"91","author":"Arora","year":"2018","journal-title":"Neurology"},{"issue":"4","key":"noi260023r34","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/mds.29317","article-title":"Clinical diagnostic accuracy of Parkinson disease: where do we stand?","volume":"38","author":"Virameteekul","year":"2023","journal-title":"Mov Disord"},{"issue":"3","key":"noi260023r35","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/mds.29304","article-title":"Pathological validation of the MDS criteria for the diagnosis of multiple system atrophy.","volume":"38","author":"Virameteekul","year":"2023","journal-title":"Mov Disord"},{"issue":"6","key":"noi260023r36","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1016\/j.hrthm.2015.03.029","article-title":"2015 Heart Rhythm Society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.","volume":"12","author":"Sheldon","year":"2015","journal-title":"Heart Rhythm"},{"key":"noi260023r37","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2021.102828","article-title":"Postural orthostatic tachycardia syndrome (POTS): state of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting\u2014part 1.","volume":"235","author":"Vernino","year":"2021","journal-title":"Auton Neurosci"},{"key":"noi260023r18","first-page":"1","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Deeks","year":"2019"},{"key":"noi260023r16","unstructured":"Wells? G, Shea? B, O\u2019Connell? D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Accessed June 30, 2025. https:\/\/ohri.ca\/en\/who-we-are\/core-facilities-and-platforms\/ottawa-methods-centre\/newcastle-ottawa-scale"},{"key":"noi260023r22","doi-asserted-by":"crossref","unstructured":"Castro? RA, Vernetti? PM, Biaggioni? I, Raj? SR, Kaufmann? H, Shibao? CA. Long-term outcomes of hyperadrenergic orthostatic hypotension.? Res Sq. Preprint posted online September 11, 2023. doi:10.21203\/rs.3.rs-3318273\/v1","DOI":"10.21203\/rs.3.rs-3318273\/v1"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2848689\/jamaneurology_virameteekul_2026_oi_260023_1782409432.05384.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T15:00:27Z","timestamp":1783954827000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2848689"}},"subtitle":["A Systematic Review and Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2026.0989","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}